Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery
NCT07593339Not yet recruiting
- Sponsor
- Başakşehir Çam & Sakura City Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of indocyanine green in epithelial ovarian cancer (EOC), sponsored by Başakşehir Çam & Sakura City Hospital. Primary endpoint: Detection rate of sentinel lymph nodes. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT07593339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07593339.